Levosimendan’s ability on veno-arterial extracorporeal membrane oxygenation weaning: Evidence says yes!

Abstract

Get full access to this article

View all access options for this article.

References

Hau

Fong

K-M

S-Y

. Levosimendan’s effect on venoarterial extracorporeal membrane oxygenation weaning. Int J Artif Organs 2022; 45: 571–579.

Bertini

Paternoster

Landoni

, et al. Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis. Minerva Cardiol Angiol. Epub ahead of print 10 June 2022. DOI: 10.23736/s2724-5683.22.06054-9

Yang

Zhao

Guo

, et al. Short-term effects of levosimendan use for venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis. Perfusion. Epub ahead of print 23 October 2021. DOI: 10.1177/02676591211051860

Kaddoura

Omar

Ibrahim

MIM

, et al. The effectiveness of levosimendan on veno-arterial extracorporeal membrane oxygenation management and outcome: A systematic review and meta-analysis. J Cardiothorac Vasc Anesth 2021; 35: 2483–2495.

Chen

Y-W

Lee

W-C

P-J

, et al. Early levosimendan administration improved weaning success rate in extracorporeal membrane oxygenation in patients with Cardiogenic Shock. Front Cardiovasc Med 2022; 9: 912321.

Alonso-Fernandez-Gatta

Merchan-Gomez

Gonzalez-Cebrian

, et al. Levosimendan in veno-arterial extracorporeal membrane oxygenator supported patients: impact on the success of weaning and survival. Artif Organs 2021; 45: 717–725.

Guilherme

Jacquet-Lagrèze

Pozzi

, et al. Correction to: can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis. Crit Care 2020; 24(1): 487.